Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study

We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 &a...

Full description

Bibliographic Details
Main Authors: Noor Barak Almandil, Muhammad Taha, Rai Khalid Farooq, Amani Alhibshi, Mohamed Ibrahim, El Hassane Anouar, Mohammed Gollapalli, Fazal Rahim, Muhammad Nawaz, Syed Adnan Ali Shah, Qamar Uddin Ahmed, Zainul Amiruddin Zakaria
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/24/6/1002
id doaj-b06a560c519246fabd49a80c32aafcd6
record_format Article
spelling doaj-b06a560c519246fabd49a80c32aafcd62020-11-24T22:19:29ZengMDPI AGMolecules1420-30492019-03-01246100210.3390/molecules24061002molecules24061002Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking StudyNoor Barak Almandil0Muhammad Taha1Rai Khalid Farooq2Amani Alhibshi3Mohamed Ibrahim4El Hassane Anouar5Mohammed Gollapalli6Fazal Rahim7Muhammad Nawaz8Syed Adnan Ali Shah9Qamar Uddin Ahmed10Zainul Amiruddin Zakaria11Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Neuroscience Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Neuroscience Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Chemistry, College of Sciences and Humanities, Prince Sattam bin Abdulaziz University, P.O. Box 83, Al-Kharij 11942, Saudi ArabiaCollege of Computer Science & Information Technology (CCSIT) Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Chemistry, Hazara University, Mansehra 21300, Khyber Pakhtunkhwa, PakistanDepartment of Nano-Medicine Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaFaculty of Pharmacy, Universiti Teknologi MARA Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D.E., MalaysiaDepartment of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, 25200 Kuantan Pahang DM, MalaysiaDepartment of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, MalaysiaWe have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.http://www.mdpi.com/1420-3049/24/6/1002quinoxaline analogssynthesisthymidine phosphorylase inhibitionmolecular docking
collection DOAJ
language English
format Article
sources DOAJ
author Noor Barak Almandil
Muhammad Taha
Rai Khalid Farooq
Amani Alhibshi
Mohamed Ibrahim
El Hassane Anouar
Mohammed Gollapalli
Fazal Rahim
Muhammad Nawaz
Syed Adnan Ali Shah
Qamar Uddin Ahmed
Zainul Amiruddin Zakaria
spellingShingle Noor Barak Almandil
Muhammad Taha
Rai Khalid Farooq
Amani Alhibshi
Mohamed Ibrahim
El Hassane Anouar
Mohammed Gollapalli
Fazal Rahim
Muhammad Nawaz
Syed Adnan Ali Shah
Qamar Uddin Ahmed
Zainul Amiruddin Zakaria
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
Molecules
quinoxaline analogs
synthesis
thymidine phosphorylase inhibition
molecular docking
author_facet Noor Barak Almandil
Muhammad Taha
Rai Khalid Farooq
Amani Alhibshi
Mohamed Ibrahim
El Hassane Anouar
Mohammed Gollapalli
Fazal Rahim
Muhammad Nawaz
Syed Adnan Ali Shah
Qamar Uddin Ahmed
Zainul Amiruddin Zakaria
author_sort Noor Barak Almandil
title Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
title_short Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
title_full Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
title_fullStr Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
title_full_unstemmed Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study
title_sort synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2019-03-01
description We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.
topic quinoxaline analogs
synthesis
thymidine phosphorylase inhibition
molecular docking
url http://www.mdpi.com/1420-3049/24/6/1002
work_keys_str_mv AT noorbarakalmandil synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT muhammadtaha synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT raikhalidfarooq synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT amanialhibshi synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT mohamedibrahim synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT elhassaneanouar synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT mohammedgollapalli synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT fazalrahim synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT muhammadnawaz synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT syedadnanalishah synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT qamaruddinahmed synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
AT zainulamiruddinzakaria synthesisofthymidinephosphorylaseinhibitorbasedonquinoxalinederivativesandtheirmoleculardockingstudy
_version_ 1725778914060533760